Skip to main content
Screener/Healthcare/Biotechnology

RARE — Ultragenyx Pharmaceutical Inc.

NASDAQ
$28.91-0.12 (-0.41%)
Mid CapUnder $50HealthcareHigh ROELow Beta
$18.29
$42.37
$28.50
$29.39
EPS (TTM)$-6.11
P/E Ratio-4.26
Dividend Yield—
Market Cap$2.70B
Volume1.13M
Prev Close$29.03
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$136.0M-$185.0M$-1.8477.9%-136.0%
Q4 '25$207.0M-$129.0M$-1.2986.0%-62.3%
Q3 '25$159.9M-$180.4M$-1.8182.5%-112.8%
Q2 '25$166.5M-$115.0M$-1.1786.2%-69.0%
Q1 '25$139.3M-$151.1M$-1.5779.4%-108.5%
Q4 '24$164.9M-$133.4M$-1.3989.8%-80.9%
Q3 '24$139.5M-$133.5M$-1.4084.9%-95.7%
Q2 '24$147.0M-$131.6M$-1.5285.5%-89.5%
Get Your Daily Market Recap